Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Assembly Biosciences, Inc (ASMB)

Pharmaceutical Preparations

https://www.assemblybio.com

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, that are designed to restore health to a dysbiotic microbiome. The firm's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Its program targets high-recurrence genital herpes associated with herpes simplex virus type 2 (HSV-2) infection and research programs focused on the discovery of novel antivirals to treat devastating viral diseases, including hepatitis delta virus (HDV) and transplant-related herpesviruses.

331 OYSTER POINT BLVD., FOURTH FLOOR
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/17/2010

Market Cap

91,566,431

Shares Outstanding

65,790,000

Weighted SO

65,793,401

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

SPRO --.--%

ACHL --.--%

TIL --.--%

NLTX --.--%

CTMX --.--%

NUVB --.--%

NXTC --.--%

Beta

0.6450

Last Div

0.0000

Range

7.68-20.04

Chg

0.3600

Avg Vol

14448

Mkt Cap

91566431

Exch

NASDAQ

Country

US

Phone

833 509 4583

DCF Diff

13.4666

DCF

0.9635

Div Yield

0.0000

P/S

4.2627

EV Multiple

-1.4708

P/FV

2.3478

Div Yield %

0.0000

P/E

-1.7852

PEG

-0.0432

Payout

0.0000

Current Ratio

2.7361

Quick Ratio

2.7361

Cash Ratio

0.4654

DSO

6.7967

DIO

0.0000

Op Cycle

6.7967

DPO

1107.4432

CCC

-1100.6465

Gross Margin

0.9877

Op Margin

-2.3524

Pretax Margin

-2.1029

Net Margin

-2.1233

Eff Tax Rate

-0.0069

ROA

-0.3955

ROE

-1.2155

ROCE

-0.6824

NI/EBT

1.0097

EBT/EBIT

0.8939

EBIT/Rev

-2.3524

Debt Ratio

0.0151

D/E

0.0503

LT Debt/Cap

0.0128

Total Debt/Cap

0.0479

Int Coverage

0.0000

CF/Debt

13.9364

Equity Multi

3.3252

Rec Turnover

53.7025

Pay Turnover

0.3296

Inv Turnover

0.0000

FA Turnover

10.3274

Asset Turnover

0.1863

OCF/Share

4.3123

FCF/Share

4.2706

Cash/Share

19.3556

OCF/Sales

1.1328

FCF/OCF

0.9903

CF Coverage

13.9364

ST Coverage

18.7900

CapEx Coverage

103.5447

Div&CapEx Cov

103.5447

P/BV

2.3478

P/B

2.3478

P/S

4.2627

P/E

-1.7852

P/FCF

3.7998

P/OCF

3.3463

P/CF

3.3463

PEG

-0.0432

P/S

4.2627

EV Multiple

-1.4708

P/FV

2.3478

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 10, 16:05 Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Revenue Product Segmentation